🇺🇸 FDA
Patent

US 10900042

Chimeric antigen receptors targeting B-cell maturation antigen

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 10900042 (Chimeric antigen receptors targeting B-cell maturation antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P35/00